home / stock / allr / allr news

ALLR News and Press, Allarity Therapeutics Inc. From 09/14/23

Stock Information
Company Name: Allarity Therapeutics Inc.
Stock Symbol: ALLR
Market: NASDAQ
Website: allarity.com
Menu
ALLR ALLR Quote ALLR Short ALLR News ALLR Articles ALLR Message Board
Get ALLR Alerts

News, Short Squeeze, Breakout and More Instantly...
ALLR - Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP(R) Technology

CAMBRIDGE, MA / ACCESSWIRE / September 14, 2023 / Allarity Therapeutics (NASDAQ:ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics. The company's unique approach involves utilizing its p...
ALLR - TIO, ACER and BDRX among pre-market losers

2023-09-01 08:42:36 ET Aditxt ( ADTX ) -49% announces $10.0 Million private placement priced at-the-market under Nasdaq rules. iCoreConnect ( ICCT ) -22% . Flora Growth Corp. ( FLGC ) -17% . Biodexa Pharmaceuticals ( BDRX ) -15% . Tingo ...

ALLR - Mesoblast, Longeveron, Lifecore Biomedical among healthcare movers

2023-08-31 10:00:40 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half XLV Vs. VHT: A Head-To-Head Healthcare ETF C...

ALLR - CRM, SHOP and MVST are among pre market gainers

2023-08-31 08:26:12 ET Prime Number Acquisition  ( NCNC ) +39% . Allarity Therapeutics ( ALLR ) +35% . iCoreConnect ( ICCT ) +34% . NLS Pharmaceutics ( NLSP ) +19% . Tingo Group ( TIO ) +14% Reports Second Quarter 2023 Financi...
ALLR - PLOS ONE Publishes Data on Allarity Therapeutics' DRP® Companion Diagnostic for Dovitinib

- T he DRP ® -Dovitinib companion diagnostic demonstrated an ability to identify advanced renal cell carcinoma patients that have improved clinical benefit from dovitinib treatment , as compared to unselected patients BOSTON (August...

ALLR - NCLH, IONQ and MNK among pre-market losers

2023-08-01 08:38:44 ET TG Therapeutics ( TGTX ) -40% after Q2 earning release . ZoomInfo Technologies ( ZI ) -20% after Q2 earning release . Vision Marine Technologies ( VMAR ) -18% on direct registered offering of 0.49M shares at $4.05 . Ze...

ALLR - PLTR, W and IONQ are among pre market gainers

2023-07-31 08:37:42 ET China Natural Resources ( NASDAQ: CHNR ) +49% . Allarity Therapeutics ( ALLR ) +31% . Barnes & Noble Education ( BNED ) +17% . Spero Therapeutics ( SPRO ) +13% Announces Special Protocol Assessment Agreement with FDA...
ALLR - Allarity Therapeutics and FivepHusion Announce Collaboration to Support Clinical Development of Deflexifol(TM) with DRP® Companion Diagnostics

BOSTON and SYDNEY (July 31, 2023) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP ® companion diagnostics for personalized cancer care, and Detsa...

ALLR - Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives

New appointments bring therapeutic development expertise and proven leadership to support continu ed progress of Allarity’s mult i ple oncology clinical programs BOSTON (July 24, 2023) — Allarity Therapeutics, Inc. (Allarit...

ALLR - NVAX and OM among healthcare movers

2023-07-10 10:03:22 ET Gainers: NanoString Technologies ( NSTG ) +23% . NeuroOne Medical Technologies Corporation ( NMTC ) +21% . Novavax ( NVAX ) +18% . Sientra ( SIEN ) +15% . Losers: Outset Medical ( OM ) -12% . PainRe...
Previous 10 Next 10